Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001641172-25-024659
Filing Date
2025-08-18
Accepted
2025-08-18 17:19:39
Documents
16

Document Format Files

Seq Description Document Type Size
1 F-1 formf-1.htm F-1 497930
2 EX-5.1 ex5-1.htm EX-5.1 15394
3 EX-23.1 ex23-1.htm EX-23.1 6256
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 27110
5 GRAPHIC formf-1_001.jpg GRAPHIC 13860
6 GRAPHIC ex5-1_001.jpg GRAPHIC 40999
  Complete submission text file 0001641172-25-024659.txt   746664

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5479
Mailing Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608
Business Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

EIN.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-289703 | Film No.: 251228882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)